A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2011
05/24/2011	CA2341507C Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
05/19/2011	WO2011060026A1 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
05/19/2011	WO2011059080A1 Isotope-substituted diamine derivative
05/19/2011	WO2011059037A1 Pharmaceutical composition for external use
05/19/2011	WO2011058933A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing same
05/19/2011	WO2011058932A1 N-benzyl amide derivative and pharmaceutical composition containing same
05/19/2011	WO2011058766A1 Aryl carboxamide derivatives as ttx-s blockers
05/19/2011	WO2011058331A1 Pemirolast for the treatment of systemic low grade inflammation
05/19/2011	WO2011058112A1 Fused bicyclic pyrazole derivatives as kinase inhibitors
05/19/2011	WO2011058111A1 Aminopurine derivatives as kinase inhibitors
05/19/2011	WO2011058110A1 Quinoline and quinoxaline derivatives as kinase inhibitors
05/19/2011	WO2011058109A1 Fused bicyclic pyrrole and imidazole derivatives as kinase inhibitors
05/19/2011	WO2011058108A1 Quinoline and quinoxaline derivatives as kinase inhibitors
05/19/2011	WO2011057892A1 2,3-dihydrobenzoxazine and 2,3-dihydrobenzothiazine derivates as hif-inhibitors for the treatment of cancer and inflammatory diseases
05/19/2011	WO2011057387A1 Nitric oxide amino acid esters for the treatment of chronic pain
05/19/2011	WO2011057332A1 Anti-inflammatory compounds
05/19/2011	WO2011057327A1 Anti-inflammatory extract
05/19/2011	WO2011007350A3 Use of nle proteins and tissue - targeted delivery system thereof for the treatment of imune-related disorders
05/19/2011	WO2010151784A3 Antimicrobial compounds
05/19/2011	WO2010130799A3 Method for impregnation with supercritical co2
05/19/2011	US20110118470 Nitrogen-containing aromatic derivatives
05/19/2011	US20110118352 Oat extracts: refining, compositions and methods of use
05/19/2011	US20110118349 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
05/19/2011	US20110118315 5-lipoxygenase-activating protein (flap) inhibitors
05/19/2011	US20110118311 Azole compound
05/19/2011	US20110118305 Compounds
05/19/2011	US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
05/19/2011	US20110118301 Amino-Aza-Adamantane Derivatives and Methods of Use
05/19/2011	US20110118287 Bicycloheteroaryl Compounds As P2X7 Modulators and Uses Thereof
05/19/2011	US20110118284 Thienopyrimidine compounds
05/19/2011	US20110118281 Compounds for inflammation and immune-related uses
05/19/2011	US20110118275 OXAZOLO[4,5-c]PYRIDINE SUBSTITUTED PYRAZINE
05/19/2011	US20110118273 Pyrrolo-pyridine, pyrrolo-pyrimidine and related heterocyclic compounds
05/19/2011	US20110118271 Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
05/19/2011	US20110118269 Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases
05/19/2011	US20110118260 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group
05/19/2011	US20110118259 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/19/2011	US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors
05/19/2011	US20110118257 Novel kinase modulators
05/19/2011	US20110118253 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors
05/19/2011	US20110118248 Heteroaryl sulfonamides and CCR2/CCR9
05/19/2011	US20110118246 Novel Compounds
05/19/2011	US20110118245 Raf kinase modulator compounds and methods of use thereof
05/19/2011	US20110118243 Anti-inflammatory drug delivery system
05/19/2011	US20110118241 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2
05/19/2011	US20110118233 Certain Substituted Amides, Method of Making, and Method of Use Thereof
05/19/2011	US20110118231 Modulators of 5-ht receptors and methods of use thereof
05/19/2011	US20110118227 Methods for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome
05/19/2011	US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them
05/19/2011	US20110118214 Ligands specific for cannabinoid receptor subtype 2
05/19/2011	US20110118210 Aminopropanol derivatives
05/19/2011	US20110118208 Thiazolyl-Dihydro-Indazoles
05/19/2011	US20110118198 Polysulfated glycosides and salts thereof
05/19/2011	US20110118186 Synthetic peptide amides and dimeric forms thereof
05/19/2011	US20110117207 Use of eggshell membrane formulations to alleviate joint pain
05/19/2011	US20110117191 Mixture of substances on the basis of a mixture of essential oils and use
05/19/2011	US20110117187 Topical compositions and methods for epithelial-related conditions
05/19/2011	US20110117184 Compositions for mucosal delivery of agents
05/19/2011	US20110117179 Compositions comprising elemental metals and uses therefor
05/19/2011	US20110117175 Sweet analgesic for use in medical procedures or treatments
05/19/2011	US20110117151 Device,system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
05/19/2011	US20110117150 Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
05/19/2011	US20110117114 Neovascular-Targeted Immunoconjugates
05/19/2011	US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
05/19/2011	US20110117111 Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
05/19/2011	US20110117106 Uses of calpain inhibitors to inhibit inflammation
05/19/2011	US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011	US20110117092 Compositions and methods for inhibiting g-csfr
05/19/2011	US20110117084 Vandetanib derivatives
05/19/2011	US20110117059 Composition of soluble indigestible fibre and of microalgae used in the well-being field
05/19/2011	US20110117039 Antioxidant, anti-inflammatory or anti-aging composition containing taxus cambium- or procambium-derived cell line as active ingredient
05/19/2011	US20110117021 Fully human anti-vap-1 monoclonal antibodies
05/19/2011	US20110117009 Drug conjugates with polyglycerols
05/19/2011	US20110117008 Use of avicins to deliver therapeutic and diagnostic agents
05/19/2011	CA2780860A1 Pharmaceutical composition for external use
05/19/2011	CA2780382A1 Pemirolast for the treatment of systemic low grade inflammation
05/19/2011	CA2780243A1 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
05/19/2011	CA2780144A1 Composition and methods for affecting cytokines and nf-kb
05/19/2011	CA2777682A1 Dendrimer compositions and methods of synthesis
05/18/2011	EP2322644A1 Methods for producing modified glycoproteins
05/18/2011	EP2322601A1 Method of collecting placental stem cells
05/18/2011	EP2322553A2 Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
05/18/2011	EP2322525A1 Purine derivatives for use as adenosin A2A receptor agonists
05/18/2011	EP2322507A1 Matrix metalloproteinase inhibitors
05/18/2011	EP2322243A1 Pharmaceutical products and compositions comprising formoterol, ciclesonide and tiotropium
05/18/2011	EP2322229A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF)
05/18/2011	EP2322228A1 T cell receptor fusions and conjugates and methods of use thereof
05/18/2011	EP2322226A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation
05/18/2011	EP2322220A1 Therapeutic agent or preventive agent for osteoarthritis
05/18/2011	EP2322218A1 Methods of modulating CD200 receptors
05/18/2011	EP2322185A2 Polynucleotide therapy
05/18/2011	EP2322165A1 Apo2 ligand/TRAIL formulations
05/18/2011	EP2322164A2 Carbonylamino derivatives useful for the treatment of inflammatory bowel disease
05/18/2011	EP2322161A1 Composition for preventing and treating odontostomatological pathologies of animals
05/18/2011	EP2322154A2 Methods for detecting and clearing cross beta structure comprising proteins with crossbeta structure binding compounds.
05/18/2011	EP2321285A1 Diazepan and piperazine derivatives modulators of chemokine receptors
05/18/2011	EP2321281A2 Anti inflammatory compounds
05/18/2011	EP2321264A2 Deacetylase inhibitors and uses thereof
05/18/2011	EP2320951A2 Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
05/18/2011	EP2320905A1 Novel adenine derivatives

1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 1272